TNCY
MCID: CYN002
MIFTS: 45

Cyanosis, Transient Neonatal (TNCY)

Categories: Blood diseases, Fetal diseases, Genetic diseases

Aliases & Classifications for Cyanosis, Transient Neonatal

MalaCards integrated aliases for Cyanosis, Transient Neonatal:

Name: Cyanosis, Transient Neonatal 57 29 13 6 40 72
Cyanosis 44 33
Tncy 57 74
Cyanosis Transient Neonatal 74

Characteristics:

OMIM:

57
Inheritance:
autosomal dominant

Miscellaneous:
onset at birth
spontaneously resolves by 5 to 6 months of age


HPO:

32
cyanosis, transient neonatal:
Inheritance autosomal dominant inheritance
Onset and clinical course congenital onset


Classifications:



External Ids:

OMIM 57 613977
MeSH 44 D003490
ICD10 33 R23.0
MedGen 42 C3151421
UMLS 72 C3151421

Summaries for Cyanosis, Transient Neonatal

OMIM : 57 Neonatal cyanosis is characterized by symptoms in the fetus and neonate that gradually abate by 5 to 6 months of age. The disorder is caused by a defect in the fetal hemoglobin chain, which causes reduced affinity for oxygen due to steric inhibition of oxygen binding and/or due to increased oxidation of the fetal hemoglobin molecule to methemoglobin (Hb FM), which has decreased oxygen-binding capacity. Some patients develop anemia resulting from increased destruction of red cells containing abnormal or unstable hemoglobin. The cyanosis resolves spontaneously by 5 to 6 months of age or earlier, as the adult beta-globin chain (HBB; 141900) is produced and replaces the fetal gamma-globin chain (summary by Crowley et al., 2011). (613977)

MalaCards based summary : Cyanosis, Transient Neonatal, also known as cyanosis, is related to cyanosis and hepatic disease and rombo syndrome, and has symptoms including cyanosis An important gene associated with Cyanosis, Transient Neonatal is HBG2 (Hemoglobin Subunit Gamma 2). The drugs Sodium citrate and Amoxicillin have been mentioned in the context of this disorder. Affiliated tissues include heart, lung and liver, and related phenotypes are hepatomegaly and anemia

UniProtKB/Swiss-Prot : 74 Cyanosis transient neonatal: A disorder characterized by cyanosis in the fetus and neonate, due to a defect in the fetal hemoglobin chain which has reduced affinity for oxygen. Some patients develop anemia resulting from increased destruction of red cells containing abnormal or unstable hemoglobin. The cyanosis resolves spontaneously by 5 to 6 months of age or earlier, as the adult beta-globin chain is produced and replaces the fetal gamma-globin chain.

Related Diseases for Cyanosis, Transient Neonatal

Diseases related to Cyanosis, Transient Neonatal via text searches within MalaCards or GeneCards Suite gene sharing:

(showing 273, show less)
# Related Disease Score Top Affiliating Genes
1 cyanosis and hepatic disease 12.4
2 rombo syndrome 12.0
3 hereditary methemoglobinemia 11.7
4 methemoglobinemia due to deficiency of methemoglobin reductase 11.7
5 tetralogy of fallot 11.6
6 hemoglobinopathy toms river 11.6
7 methemoglobinemia, beta-globin type 11.5
8 heart disease 11.4
9 transposition of the great arteries 11.4
10 eisenmenger syndrome 11.4
11 heterotaxy 11.4
12 sulfhemoglobinemia 11.4
13 tricuspid atresia 11.3
14 pulmonary venous return anomaly 11.3
15 buerger disease 11.3
16 alveolar capillary dysplasia with misalignment of pulmonary veins 11.3
17 central hypoventilation syndrome, congenital 11.3
18 methemoglobinemia, beta type 11.2
19 methemoglobinemia, alpha type 11.2
20 arterial calcification of infancy 11.2
21 pulmonary atresia with intact ventricular septum 11.2
22 seizures, benign familial infantile, 1 11.2
23 acrocephalopolysyndactyly type iii 11.0
24 emphysema, congenital lobar 11.0
25 laryngomalacia 11.0
26 pulmonary fibrosis, idiopathic 11.0
27 neuropathy, hereditary sensory and autonomic, type iii 11.0
28 methemoglobinemia and ambiguous genitalia 11.0
29 obesity-hypoventilation syndrome 11.0
30 glycogen storage disease of heart, lethal congenital 11.0
31 lymphangiectasia, pulmonary, congenital 11.0
32 hypomagnesemia 1, intestinal 11.0
33 pulmonary alveolar proteinosis, acquired 11.0
34 pitt-hopkins syndrome 11.0
35 reynolds syndrome 11.0
36 episodic pain syndrome, familial, 1 11.0
37 chronic mountain sickness 11.0
38 hypoplastic right heart syndrome 11.0
39 esophageal atresia/tracheoesophageal fistula 11.0
40 silicosis 11.0
41 severe pre-eclampsia 11.0
42 blue toe syndrome 11.0
43 congenital myasthenic syndrome 11.0
44 pulmonary venoocclusive disease 11.0
45 congenital laryngeal palsy 11.0
46 infantile apnea 11.0
47 right ventricle hypoplasia 11.0
48 tracheal agenesis 11.0
49 critical congenital heart disease 11.0
50 univentricular heart 11.0
51 heart septal defect 10.7
52 methemoglobinemia 10.7
53 atrial heart septal defect 10.6
54 pulmonary hypertension 10.5
55 liver cirrhosis 10.4
56 patent foramen ovale 10.4
57 pulmonary arteriovenous fistulas 10.4
58 ventricular septal defect 10.4
59 arteriovenous malformation 10.4
60 polycythemia 10.4
61 pulmonary arteriovenous malformation 10.3
62 patent ductus arteriosus 1 10.3
63 congenital methemoglobinemia 10.3
64 hepatopulmonary syndrome 10.3
65 cor triatriatum 10.3
66 cor triatriatum dexter 10.3
67 liver disease 10.3
68 single ventricular heart 10.3
69 tricuspid valve insufficiency 10.2
70 congestive heart failure 10.2
71 pulmonary hypertension, primary, 1 10.2
72 pulmonary valve stenosis 10.2
73 pulmonary arterio-veinous fistula 10.2
74 mitral valve stenosis 10.2
75 lung disease 10.2
76 pulmonary embolism 10.2
77 anoxia 10.2
78 interatrial communication 10.2
79 hydrops, lactic acidosis, and sideroblastic anemia 10.1
80 deficiency anemia 10.1
81 telangiectasis 10.1
82 hemoglobinopathy 10.1
83 pneumonia 10.1
84 portal hypertension 10.1
85 double outlet right ventricle 10.1
86 dextrocardia 10.1
87 aneurysm 10.1
88 hypoxia 10.1
89 acquired methemoglobinemia 10.1
90 argyria 10.1
91 ebstein anomaly 10.0
92 sudden infant death syndrome 10.0
93 cardiac arrest 10.0
94 hemopericardium 10.0
95 hereditary hemorrhagic telangiectasia 10.0
96 tricuspid valve stenosis 10.0
97 bronchitis 10.0
98 situs inversus 10.0
99 hypoplastic left heart syndrome 10.0
100 aortic arch interruption 10.0
101 atrial septal defect coronary sinus 10.0
102 carcinoid syndrome 10.0
103 noonan syndrome 1 9.9
104 pulmonary atresia with ventricular septal defect 9.9
105 dowling-degos disease 1 9.9
106 schistosoma mansoni infection, susceptibility/ 9.9
107 scleroderma, familial progressive 9.9
108 methemoglobin reductase deficiency 9.9
109 pulmonary alveolar microlithiasis 9.9
110 dermatitis herpetiformis, familial 9.9
111 atrioventricular septal defect 9.9
112 alpha-1-antitrypsin deficiency 9.9
113 rheumatic heart disease 9.9
114 endocarditis 9.9
115 respiratory failure 9.9
116 pulmonary edema 9.9
117 cardiac tamponade 9.9
118 pericardial effusion 9.9
119 persistent fetal circulation syndrome 9.9
120 schistosomiasis 9.9
121 urticaria 9.9
122 pericarditis 9.9
123 cerebral palsy 9.9
124 hepatitis 9.9
125 dermatitis 9.9
126 aortic aneurysm 9.9
127 hemolytic anemia 9.9
128 dermatitis herpetiformis 9.9
129 hypereosinophilic syndrome 9.9
130 microcephaly 9.9
131 48,xyyy 9.9
132 double discordia 9.9
133 pseudo-turner syndrome 9.9
134 raynaud phenomenon 9.9
135 headache 9.9
136 hypertonia 9.9
137 syncope 9.9
138 congenital portosystemic shunt 9.9
139 levocardia 9.9
140 persistent eustachian valve 9.9
141 amyotrophic lateral sclerosis 1 9.8
142 atrial standstill 1 9.8
143 gastroesophageal reflux 9.8
144 fibrosis of extraocular muscles, congenital, 1 9.8
145 attention deficit-hyperactivity disorder 9.8
146 lipomatosis, multiple 9.8
147 systemic lupus erythematosus 9.8
148 pulmonary hemosiderosis 9.8
149 raynaud disease 9.8
150 sarcoidosis 1 9.8
151 triiodothyronine receptor auxiliary protein 9.8
152 down syndrome 9.8
153 varicose veins 9.8
154 vitiligo-associated multiple autoimmune disease susceptibility 6 9.8
155 wolff-parkinson-white syndrome 9.8
156 chiari malformation type ii 9.8
157 multinucleated neurons, anhydramnios, renal dysplasia, cerebellar hypoplasia, and hydranencephaly 9.8
158 leprosy 3 9.8
159 pulmonic stenosis 9.8
160 reticulum cell sarcoma 9.8
161 anemia, nonspherocytic hemolytic, due to g6pd deficiency 9.8
162 stroke, ischemic 9.8
163 branchiootic syndrome 1 9.8
164 dermatitis, atopic 9.8
165 vitiligo-associated multiple autoimmune disease susceptibility 1 9.8
166 pulmonary disease, chronic obstructive 9.8
167 aortic aneurysm, familial thoracic 1 9.8
168 nasopharyngeal carcinoma 9.8
169 anxiety 9.8
170 angina pectoris 9.8
171 arrhythmogenic right ventricular cardiomyopathy 9.8
172 visceral heterotaxy 9.8
173 metabolic acidosis 9.8
174 limb ischemia 9.8
175 fibroma 9.8
176 inflammatory myofibroblastic tumor 9.8
177 pain agnosia 9.8
178 atrial fibrillation 9.8
179 scoliosis 9.8
180 adenoid hypertrophy 9.8
181 umbilical hernia 9.8
182 thrombosis 9.8
183 postural orthostatic tachycardia syndrome 9.8
184 pleomorphic lipoma 9.8
185 meningoencephalitis 9.8
186 sarcoma 9.8
187 plethora of newborn 9.8
188 disseminated intravascular coagulation 9.8
189 adult respiratory distress syndrome 9.8
190 gestational diabetes 9.8
191 hepatorenal syndrome 9.8
192 visual epilepsy 9.8
193 allergic hypersensitivity disease 9.8
194 hemosiderosis 9.8
195 pyloric stenosis 9.8
196 diarrhea 9.8
197 tuberous sclerosis 9.8
198 cholestasis 9.8
199 biliary atresia 9.8
200 toxic shock syndrome 9.8
201 capillary leak syndrome 9.8
202 candidiasis 9.8
203 thrombocytopenia 9.8
204 factitious disorder 9.8
205 vascular disease 9.8
206 hepatitis c 9.8
207 lutembacher's syndrome 9.8
208 autoimmune hepatitis 9.8
209 intestinal perforation 9.8
210 lateral sclerosis 9.8
211 arteriosclerosis 9.8
212 post-thrombotic syndrome 9.8
213 dyskeratosis congenita 9.8
214 skin atrophy 9.8
215 idiopathic interstitial pneumonia 9.8
216 pulmonary tuberculosis 9.8
217 adenocarcinoma 9.8
218 glioblastoma multiforme 9.8
219 interstitial lung disease 9.8
220 ischemia 9.8
221 gastric adenocarcinoma 9.8
222 pulmonary fibrosis 9.8
223 gastritis 9.8
224 intracranial thrombosis 9.8
225 spindle cell sarcoma 9.8
226 hypotrichosis 9.8
227 nutritional deficiency disease 9.8
228 dystonia 9.8
229 aortic valve insufficiency 9.8
230 connective tissue disease 9.8
231 cerebral angioma 9.8
232 achenbach syndrome 9.8
233 cerebrovascular disease 9.8
234 myocarditis 9.8
235 cataract 9.8
236 influenza 9.8
237 lupus erythematosus 9.8
238 erythromelalgia 9.8
239 cleft lip 9.8
240 intracranial hypertension 9.8
241 primary ciliary dyskinesia 9.8
242 hydrocele 9.8
243 47,xyy 9.8
244 congenital hepatic fibrosis 9.8
245 alveolar capillary dysplasia 9.8
246 aortic coarctation 9.8
247 cardiac rupture 9.8
248 chiari malformation 9.8
249 chromosomal triplication 9.8
250 congenital extrahepatic portosystemic shunt 9.8
251 congenitally corrected transposition of the great arteries 9.8
252 glioblastoma 9.8
253 hansen's disease 9.8
254 myotonia atrophica 9.8
255 neonatal stroke 9.8
256 osteochondroma 9.8
257 systemic capillary leak syndrome 9.8
258 undifferentiated connective tissue disease 9.8
259 weber syndrome 9.8
260 angiomatosis 9.8
261 brain injury 9.8
262 dysautonomia 9.8
263 hypotonia 9.8
264 myotonia 9.8
265 seizure disorder 9.8
266 posttransplant acute limbic encephalitis 9.8
267 rare cardiac tumor 9.8
268 congenital systemic arteriovenous fistula 9.8
269 inferior vena cava interruption without azygos continuation 9.8
270 azygos continuation of the inferior vena cava 9.8
271 atrial septal aneurysm 9.8
272 polyendocrinopathy 9.8
273 primary adrenal insufficiency 9.8

Graphical network of the top 20 diseases related to Cyanosis, Transient Neonatal:



Diseases related to Cyanosis, Transient Neonatal

Symptoms & Phenotypes for Cyanosis, Transient Neonatal

Human phenotypes related to Cyanosis, Transient Neonatal:

32 (showing 6, show less)
# Description HPO Frequency HPO Source Accession
1 hepatomegaly 32 occasional (7.5%) HP:0002240
2 anemia 32 occasional (7.5%) HP:0001903
3 jaundice 32 occasional (7.5%) HP:0000952
4 reticulocytosis 32 occasional (7.5%) HP:0001923
5 cyanosis 32 HP:0000961
6 methemoglobinemia 32 HP:0012119

Symptoms via clinical synopsis from OMIM:

57
Skin Nails Hair Skin:
cyanosis
jaundice (in some)

Abdomen Liver:
hepatomegaly (in some)

Laboratory Abnormalities:
methemoglobinemia

Hematology:
decreased oxygen-binding capacity of hemoglobin
decreased hemoglobin oxygen saturation
anemia (in some)
reticulocytosis (in some)

Clinical features from OMIM:

613977

UMLS symptoms related to Cyanosis, Transient Neonatal:


cyanosis

Drugs & Therapeutics for Cyanosis, Transient Neonatal

Drugs for Cyanosis, Transient Neonatal (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(showing 162, show less)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Sodium citrate Approved, Investigational Phase 4 68-04-2
2
Amoxicillin Approved, Vet_approved Phase 4 26787-78-0 33613
3
Caffeine Approved Phase 4 58-08-2 2519
4
Clavulanate Approved, Vet_approved Phase 4 58001-44-8 5280980
5
Ceftriaxone Approved Phase 4 73384-59-5 5479530 5361919
6
Dopamine Approved Phase 4 51-61-6, 62-31-7 681
7
Metoclopramide Approved, Investigational Phase 4 364-62-5 4168
8
Clindamycin Approved, Vet_approved Phase 4 18323-44-9 29029
9
Citric acid Approved, Nutraceutical, Vet_approved Phase 4 77-92-9 311
10
Calcium Approved, Nutraceutical Phase 4 7440-70-2 271
11 Anticoagulants Phase 4
12 Citrate Phase 4
13 Phosphodiesterase Inhibitors Phase 4
14 Nutrients Phase 4
15 Micronutrients Phase 4
16 Trace Elements Phase 4
17 Calcium, Dietary Phase 4
18 Antibiotics, Antitubercular Phase 4
19 Central Nervous System Stimulants Phase 4
20 Purinergic P1 Receptor Antagonists Phase 4
21 Caffeine citrate Phase 4
22 Fat Emulsions, Intravenous Phase 4
23 Parenteral Nutrition Solutions Phase 4
24 Soy Bean Phase 4
25 Antitubercular Agents Phase 4
26 Amoxicillin-Potassium Clavulanate Combination Phase 4
27 beta-Lactamase Inhibitors Phase 4
28 Gentamicins Phase 4
29 Anti-Bacterial Agents Phase 4
30 Anti-Infective Agents Phase 4
31 Pharmaceutical Solutions Phase 4
32 Dopamine Agents Phase 4
33 Dopamine Antagonists Phase 4
34 Dopamine D2 Receptor Antagonists Phase 4
35 Clindamycin palmitate Phase 4
36 Clindamycin phosphate Phase 4
37 Neurotransmitter Agents Phase 4
38 Adrenergic Agonists Phase 4
39 Peripheral Nervous System Agents Phase 4
40 Adrenergic beta-Agonists Phase 4
41 Adrenergic Agents Phase 4
42 Autonomic Agents Phase 4
43 Albuterol Phase 4
44 Respiratory System Agents Phase 4
45 Tocolytic Agents Phase 4
46 Adrenergic beta-2 Receptor Agonists Phase 4
47 Anti-Asthmatic Agents Phase 4
48 Bronchodilator Agents Phase 4
49
Enalapril Approved, Vet_approved Phase 3 75847-73-3 5362032 40466924
50
Enalaprilat Approved Phase 3 76420-72-9 6917719
51
Bosentan Approved, Investigational Phase 3 147536-97-8 104865
52 Fasudil Investigational Phase 3 103745-39-7
53 Angiotensin-Converting Enzyme Inhibitors Phase 3
54 Antihypertensive Agents Phase 3
55 Sildenafil Citrate Phase 3 171599-83-0
56 Phosphodiesterase 5 Inhibitors Phase 3
57 Endothelin Receptor Antagonists Phase 3
58 Vasodilator Agents Phase 3
59 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine Phase 3
60 Protein Kinase Inhibitors Phase 3
61 calcium channel blockers Phase 3
62
Nitric Oxide Approved Phase 2 10102-43-9 145068
63
Sargramostim Approved, Investigational Phase 2 83869-56-1, 123774-72-1
64
Lenograstim Approved, Investigational Phase 2 135968-09-1
65
Iron Approved, Experimental Phase 2 15438-31-0, 7439-89-6 23925 27284
66
Melatonin Approved, Nutraceutical, Vet_approved Phase 1, Phase 2 73-31-4 896
67 Protective Agents Phase 1, Phase 2
68 omega-N-Methylarginine Phase 2
69 Central Nervous System Depressants Phase 1, Phase 2
70 Free Radical Scavengers Phase 1, Phase 2
71 Antioxidants Phase 1, Phase 2
72 Hematinics Phase 2
73 Epoetin alfa Phase 2 113427-24-0
74 Iron Supplement Phase 2
75 Immunologic Factors Phase 2
76 Adjuvants, Immunologic Phase 2
77
Primaquine Approved Phase 1 90-34-6 4908
78
Dexamethasone Approved, Investigational, Vet_approved Phase 1 50-02-2 5743
79
Dexamethasone acetate Approved, Investigational, Vet_approved Phase 1 1177-87-3
80
Methadone Approved, Illicit Phase 1 76-99-3 4095
81
Budesonide Approved Phase 1 51333-22-3 63006 5281004
82 Antimalarials Phase 1
83 Antiparasitic Agents Phase 1
84 Antiprotozoal Agents Phase 1
85 Heptavalent Pneumococcal Conjugate Vaccine Phase 1
86 Vaccines Phase 1
87
protease inhibitors Phase 1
88 HIV Protease Inhibitors Phase 1
89 Hormones Phase 1
90 Gastrointestinal Agents Phase 1
91 Antiemetics Phase 1
92 Anti-Inflammatory Agents Phase 1
93 glucocorticoids Phase 1
94 Antineoplastic Agents, Hormonal Phase 1
95 Hormone Antagonists Phase 1
96 Hormones, Hormone Substitutes, and Hormone Antagonists Phase 1
97 BB 1101 Phase 1
98
Iloprost Approved, Investigational 78919-13-8 6443959
99
Ipratropium Approved, Experimental 60205-81-4, 22254-24-6 657309 43232
100
Tranexamic Acid Approved 1197-18-8 5526
101
Tranylcypromine Approved, Investigational 155-09-9 441233
102
Dobutamine Approved 34368-04-2 36811
103
tannic acid Approved 1401-55-4
104
Benzocaine Approved, Investigational 94-09-7, 1994-09-7 2337
105
Prednisone Approved, Vet_approved 53-03-2 5865
106
Fluticasone Approved, Experimental 90566-53-3 62924
107
Lidocaine Approved, Vet_approved 137-58-6 3676
108
Epinephrine Approved, Vet_approved 51-43-4 5816
109
Racepinephrine Approved 329-65-7 838
110
Prilocaine Approved 721-50-6 4906
111
Nifedipine Approved Early Phase 1 21829-25-4 4485
112
Norepinephrine Approved 51-41-2 439260
113
Apixaban Approved 503612-47-3 10182969
114
Enoxaparin Approved 9005-49-6 772
115
Ampicillin Approved, Vet_approved 69-53-4 6249
116
Turmeric Approved, Experimental, Investigational
117
Serine Approved, Nutraceutical 56-45-1 5951
118 Kava Approved, Investigational, Nutraceutical 9000-38-8
119
Imidacloprid Vet_approved 105827-78-9 86418
120 Platelet Aggregation Inhibitors
121 Cholinergic Agents
122 Cholinergic Antagonists
123 Anticonvulsants
124 Bromides
125 Hemostatics
126 Coagulants
127 Antifibrinolytic Agents
128 Anesthetics
129 Sympathomimetics
130 Cardiotonic Agents
131 Calamus
132 Anesthetics, Local
133 Sodium Channel Blockers
134 Adrenergic alpha-Agonists
135 Diuretics, Potassium Sparing
136 Epinephryl borate
137 Mydriatics
138 Anti-Arrhythmia Agents
139 Vasoconstrictor Agents
140 Anti-Allergic Agents
141 Cariostatic Agents
142 Fluorides
143 3-Iodobenzylguanidine
144 Radiopharmaceuticals
145 Vitamin B Complex
146 Immunoglobulins
147 Vitamins
148 Antibodies
149 Antibodies, Antinuclear
150 Neuroprotective Agents
151 neurokinin A
152
Substance P 33507-63-0 44359816
153 Vasoactive intestinal peptide 40077-57-4
154 Serine Proteinase Inhibitors
155 Antithrombins
156 Antithrombin III
157 Factor Xa Inhibitors
158 Chelating Agents
159 Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate
160 Chinese Salvia
161 Ginkgo
162 Astragalus

Interventional clinical trials:

(showing 88, show less)
# Name Status NCT ID Phase Drugs
1 Magnetic Resonance Imaging and Neurodevelopmental Outcomes in Preterm Infants Following Administration of High-Dose Caffeine - A Pilot Study Completed NCT00809055 Phase 4 Caffeine citrate
2 The Effects of Two Different Intravenous Lipid Emulsions on the Outcomes of Preterm Infants With Sepsis: a Randomized Pilot Controlled Trial Completed NCT03275090 Phase 4 Smoflipid ®
3 Pneumonia in Children: Aetiology, Ideal Antibiotic Duration, Quality of Life Completed NCT02258763 Phase 4 Amoxicillin-Potassium Clavulanate Combination;Placebo
4 Randomized, Controlled Clinical Trial of Day-care Based and Hospitalized Management of Severe and Very Severe Pneumonia, With Severe Malnutrition, With/Without Associated Co-morbidities in Children Completed NCT00968370 Phase 4
5 Use of Metoclopramide for the Prevention of Gastroesophageal Reflux in Premature Infants Followed in an Outpatient Kangaroo Mother Care Clinic Before 40 Weeks of Gestational Age: A Randomized Controlled Trial Recruiting NCT02907632 Phase 4 Metoclopramide;Placebo
6 A Randomized Clinical Trial Between Clindamycin Once and Thrice a Day in Septic Abortion. Recruiting NCT02309346 Phase 4 Clindamycin
7 A Prospective Study on the Use of Hypertonic Saline Inhalation in Acute Bronchiolitis in Children Not yet recruiting NCT03880903 Phase 4 normal saline and salbutamol;hypertonic saline and salbutamol;Hypertonic saline
8 Trial of ACE Inhibition in Infants With Single Ventricle (A Trial Conducted by the Pediatric Heart Network) Completed NCT00113087 Phase 3 Enalapril;Placebo
9 Combination Treatment With Bosentan and Sildenafil to Patients With Eisenmengers Syndrome Completed NCT00303004 Phase 3 Bosentan and Sildenafil
10 NEWBORN VENTILATION IN THE DELIVERY ROOM: CAN IT BE IMPROVED WITH A T-PIECE RESUSCITATOR? Multicenter Cross-over Cluster Randomized Controlled Trial Completed NCT00443118 Phase 3
11 Efficacy, Tolerability and Biology of a Rho-kinase Inhibitor (Fasudil) in the Treatment of Raynaud's Phenomenon Completed NCT00498615 Phase 3 Fasudil
12 " Ilomedin for Treatment of Septic Shock With Persistent Microperfusion Defects ", a Double-blind, Randomized Controlled Trial:The I-MICRO Trial Not yet recruiting NCT03788837 Phase 3 Ilomedin;NaCl
13 Safety and Efficacy of Umbilical Cord Mesenchymal Stem Cell Injection for Diabetes Secondary Peripheral Arterial Disease Unknown status NCT02287831 Phase 1, Phase 2
14 Solar Powered Oxygen Delivery: An Open-label Non-inferiority Comparison to Standard Oxygen Delivery Using Oxygen Cylinders Completed NCT02100865 Phase 2
15 Determination of Nitrite as a Source of Bioactive Nitric Oxide in Human Subjects Completed NCT00048477 Phase 2 L-NMMA and Sodium Nitrite
16 Effects of Melatonin as a Novel Antioxidant and Free Radicals Scavenger in Neonatal Sepsis Completed NCT03295162 Phase 1, Phase 2 Melatonin 10 mg
17 Erythropoietin to Prevent Unnecessary Transfusions In Patients With Cyanotic Congenital Heart Disease - A Prospective Randomized Control Trial Recruiting NCT02564796 Phase 2 Epoetin Alfa and Iron
18 RIGENERA 2.0 (Recupero Dall'Infarto Miocardico Con G-CSF E Nuovi Esempi di Rigenerazione Avanzata) Project: "The Combined Effect of Subcutaneous Granulocyte - Colony Stimulating Factor and Myocardial Contrast Echocardiography With Intravenous Infusion of Sulphur Hexafluoride on Post-infarction Left Ventricular Function" Suspended NCT02502747 Phase 2 rhu G-CSF;optimal standard of care
19 Impact of Early Enteral Feeding on Splanchnic Blood Flow After Surgery for Critical Heart Disease in the Newborn Terminated NCT00919945 Phase 2
20 Feasibility and Efficacy Of Negative Pressure Ventilation in Fontan populatioN: Cardiovascular Flow Assessment by Magnetic Resonance Imaging Completed NCT03251742 Phase 1
21 A Study of the Pharmacokinetics of Primaquine in Lactating Women and Breastfed Infants for the Radical Treatment of Uncomplicated Maternal P. Vivax Completed NCT01780753 Phase 1 Primaquine
22 Dynamics of the Immune Response in Children to the 23-valent Pneumococcal Capsular Polysaccharide Vaccine (Pneumovax) Completed NCT03460730 Phase 1
23 Steroid Therapy in Acute Bronchiolitis A New Old Line of Therapy. Not yet recruiting NCT03436225 Phase 1 Dexamethasone orally.;Dexamethasone parenteral.;Inhaled nebulized Budesonide.;Inhaled nebulized salbutamol.
24 Pulse Oximetry With Clinical Observation to Screen for Lung Disease in Neonates Unknown status NCT02533583
25 CA-125 and Severity of Pre-Eclampsia Unknown status NCT02704676
26 Long-term Effects on Pulmonary Function in Post- Fontan Operation Unknown status NCT01413308
27 Aerobic Exercise Increases Phosphate Removal During Hemodialysis Unknown status NCT01912417
28 Effects of Iloprost Treatment in Adult Patients With Pulmonary Arterial Hypertension Related to Congenital Heart Disease (Eisenmenger Physiology): Safety, Tolerability, Clinical, and Hemodynamic Effect. Unknown status NCT01383083
29 Detection of Pleural Effusion by Internal Thoracic Impedance Method Unknown status NCT01601444
30 Salbutamol in the Pediatric Emergencies: Nebulization Estimated Via AerogeN or Jet Unknown status NCT03042065
31 Effect of Remote Ischemic Preconditioning on Children Undergoing Cardiac Surgery: Implication of Preoperative Cyanosis Completed NCT01311310
32 Accuracy Assessment of 7 Clinical Indicators in Newborn Screening for Congenital Heart Disease Completed NCT01665261
33 Laryngomalacia Exposed Completed NCT01042223
34 Tranexamic Acid Reduces Blood Loss in Pediatric Cardiac Surgery Completed NCT00994994 Tranexamic Acid
35 ST2, a Novel Biomarker for Cardiac Remodeling in Adults With Congenital Heart Disease Completed NCT01774890
36 Retrospective Review of Neonates With Neurological Complications Following Cardiac Surgery Completed NCT00366561
37 The Effect of Remote Ischemic Preconditioning on the Ischemic Reperfusion Injury in Infants With Ventricular Septal Defect and Pulmonary Hypertension Completed NCT01313832
38 Neuromuscular Electrical Stimulation Improves Exercise Tolerance in Patients With Advanced Heart Failure on Continuous Dobutamine Use - A Randomized Controlled Trial Completed NCT02668419
39 Sleep-disordered Breathing in Eisenmenger Syndrome Completed NCT02614417
40 Use of Bubble CPAP Compared to Nasal Prong Oxygen or Humidified High Flow in Children Under Five With Severe Pneumonia and Hypoxaemia: a Randomized Trial Completed NCT01396759
41 Efficacy of Aquatic Physiotherapy in Stress Level and Muscle Tone of Children Between 3 and 24 Months With Microcephaly by Zika Virus Congenital Syndrome Completed NCT03330600
42 Short-term Effect of Slow Expiratory Techniques for Mucociliary Clearance for Clinical Improvement in Children Not Hospitalized With Mild and Moderate Bronchiolitis: Multicentre Study Completed NCT03835858
43 Assessment of Clinical Competence of Medical Students: a Comparison of High-fidelity Simulation, Serious Game and Multiple-choice Questions Completed NCT03884114
44 Neurodevelopmental Outcomes and Postoperative Hemodynamics in Children With Hypoplastic Left Heart Syndrome Completed NCT00464100
45 Intestinal Function in Neonates With Complex Congenital Heart Disease Completed NCT01475357
46 The Effect of Vest Type Dynamic Elastomeric Fabric Orthosis (DEFO) on Sitting Balance and Gross Manuel Dexterity in Children With Bilateral Cerebral Palsy: A Feasibility and Randomized, Single-blinded, Pilot Study Completed NCT03191552
47 A Randomized, Single-blinded Placebo-controlled Trial of Ischemic Preconditioning in Raynaud's Phenomenon (RP) Completed NCT02506062
48 Effects of Compression in Mixed Ulcers Completed NCT02838251
49 Mucociliary Clearance Techniques vs. High Frequency Compression of the Thoracic Wall in Children Not Hospitalized With Mild and Moderate Bronchiolitis: A Randomized Clinical Trial Completed NCT03835936
50 Methemoglobin Levels in Generally Anesthetized Pediatric Dental Patients Receiving Prilocaine Versus Lidocaine Completed NCT01402869 4% prilocaine plain;2% Lidocaine with 1:100,000 epinephrine
51 IndiaCLEN Multicentric Trial of Home Versus Hospital Oral Amoxicillin for Management of Severe Pneumonia in Children Completed NCT01386840
52 Urine and Serum Biomarkers for Early Detection of Acute Kidney Injury Following Cardiopulmonary Bypass Surgery for Congenital Heart Disease in Children and Adults: A Pilot Study Completed NCT01531985
53 Orogastric Intubation With Dental Fixation Versus Nasogastric Intubation: a Cross-over Randomized Trial Completed NCT03670238
54 PCR Technique of a Commercial Test and Blood Culture to Early Detect Sepsis in NICU Completed NCT03884894
55 Pre-warming With Thermal Gown Prevents Maternal Hypothermia in Elective Cesarean Section Completed NCT02091466
56 Assessment of Autonomic Function and Cardiovascular Response to Exercise Testing in Parkinson's Disease Patients Completed NCT03156400
57 Effect of Chronic Changes in Heart Rate on Congestive Heart Failure Completed NCT00389649
58 "Color Doppler Ultrasound Comparison of Topical 10 % Nifedipine Versus 5% Sildenafil in Secondary Raynaud: A Randomized, Double-blind, Placebo-controlled Pilot Study" Completed NCT03027674 Early Phase 1 10% nifedipine cream;5% sildenafil cream
59 Air Cleaners for Children and Adolescents With Asthma and Dog Allergy Completed NCT00220753
60 Randomized Controlled Trial (RCT) in Children With Severe Pneumonia Completed NCT00455468
61 Evaluation of an Oral Health Intervention Program for Children With Congenital Heart Defects Completed NCT03311438
62 RaynAUT - Thermography and the Autonomic Nervous System in Raynaud's Phenomenon - Investigation of the Autonomic Nervous System in Patients With Raynaud's Phenomenon, Glaucoma, and Autonomic Neuropathy. Completed NCT03094910
63 Pediatric Remote Ischemic Pre-conditioning Prior to Complex Cardiac Surgery Completed NCT01739088
64 An Investigation Into The Potential Roles Of Vasoactive Intestinal Peptide And Substance P In The Pathophysiology Of Plastic Bronchitis And Protein Losing Enteropathy In Children With Palliated Single Ventricle Physiology Completed NCT01563757
65 Pilot Project on Clinical Tolerance to a Live Attenuated Vaccine Against Influenza (Flumist®) in the Context of Influenza Vaccination in a Population Allergic to Eggs. Completed NCT02142491
66 Different Modalities for Evaluation of Fetal Cardiac Function in Pregnant Women With Rheumatic Heart Disease (RHD) Patients Recruiting NCT03095937
67 A Prospective Study on the Safety and Efficacy of Apixaban for the PReventiOn of ThromboEmbolism in Adults With Congenital HearΤ Disease and Atrial ARrhythmias Recruiting NCT03854149 Apixaban
68 Thromboprophylaxis in Pregnant Women in Hospital: A Prospective Clinical Trial Recruiting NCT02600260 Enoxaparin
69 Efficacy of Two Doses of Parenteral Amoxicillin Plus Single Dose Gentamicin Compared to Four Doses of Parenteral Ampicillin Plus Single Dose Gentamicin in Managing Children Hospitalized With WHO Classified Severe Pneumonia: a RCT Recruiting NCT03369093 Amoxicillin
70 Effects of Hydrotherapy in Premature Infants With Bronchopulmonary Dysplasia During Hospitalization: a Randomized Clinical Trial Recruiting NCT03538977
71 4DFlow Magnetic Resonance Imaging in Patients With Pulmonary Hypertension Associated With Congenital Heart Disease Recruiting NCT03928002
72 Assessment of Immediate Adverse Reactions in Children Under 2 Years of Age Following Administration of Gadoteric Acid (Gd-DOTA or Dotarem) Recruiting NCT02609919 Gadoteric Acid
73 The Effectiveness of an Empirical Chinese Medicine Formulation for Idiopathic Pulmonary Fibrosis: an Open Label Clinical Trial Recruiting NCT03274544
74 Multicenter Randomized Controlled Trial: Evaluation of the Effects of Respiratory Physiotherapy, Placebo-controlled, in Infants With Moderate Acute Bronchiolitis Recruiting NCT03753802
75 Effect of Assisted Exercise on Musculoskeletal System and Growth in Preterm Infants Active, not recruiting NCT03354988
76 Diagnosis of Ascites in Infants and Children Not yet recruiting NCT03341221
77 Factors Associated With Normal Exercise Capacity in Patients With Single Ventricle: the Multicenter Cross-sectional Study Not yet recruiting NCT04026542
78 A Study On the Risk of Nosocomial Infection in Mechanically Ventilated Neonate In NICU of Assiut University Children Hospital PROTOCOL OF THESIS Descriptive Study Not yet recruiting NCT03310840
79 Impact of Neurophysiological Facilitation of Respiration in Preterm Neonates Admitted in Level II Neonatal Intensive Care Unit: A Randomized Controlled Trail Not yet recruiting NCT04019886
80 Effect of Solar Powered Oxygen Delivery on Childhood Mortality in Uganda: A Cluster-Randomized Trial Not yet recruiting NCT03851783
81 Fenestrated Vs Non Fenestrated Extra-Cardiac Total Cavo-pulmonary Connection in Patients With Standard Preoperative Risk Profiles, A Prospective Randomized Study Not yet recruiting NCT03503032
82 Primary Spontaneous Pneumothorax and Different Types of Surgical Management Not yet recruiting NCT03804385
83 A Retrospective Review of Postoperative Management of Cyanosis Following Bidirectional Glenn Operation Terminated NCT00327886
84 Optimal Timing for Repair of Right-to-Left Shunt Lesions Terminated NCT00268099
85 Proposal for Retrospective Review of Descending Aortic Flow Reversal in Total Anomalous Pulmonary Venous Connection Terminated NCT00486070
86 Evaluation of Professional Practices on the Management of Cardiogenic Pulmonary Edema (RENAU-OAP) Terminated NCT03148847
87 Randomised Controlled Trial to Study the Effect of Nasal Continuous Positive Airway Pressure (NCPAP) Cycling on Successful Weaning When Compared With Nasal Continuous Positive Airway Pressure (NCPAP) in Premature Infants of 25-28 Weeks Gestation Terminated NCT02114112
88 Ultrasound to Predict Steal-Syndrome After Arteriovenous-Fistula Creation (UPSAC - Trial) Withdrawn NCT01468506

Search NIH Clinical Center for Cyanosis, Transient Neonatal

Cochrane evidence based reviews: cyanosis

Genetic Tests for Cyanosis, Transient Neonatal

Genetic tests related to Cyanosis, Transient Neonatal:

# Genetic test Affiliating Genes
1 Cyanosis, Transient Neonatal 29 HBG2

Anatomical Context for Cyanosis, Transient Neonatal

MalaCards organs/tissues related to Cyanosis, Transient Neonatal:

41
Heart, Lung, Liver, Skin, Testes, Brain, Kidney

Publications for Cyanosis, Transient Neonatal

Articles related to Cyanosis, Transient Neonatal:

(showing 5584, show less)
# Title Authors PMID Year
1
A hemoglobin variant associated with neonatal cyanosis and anemia. 38 8 71
21561349 2011
2
Neonatal cyanosis due to a novel fetal hemoglobin: Hb F-Circleville [Ggamma63(E7)His-->Leu, CAT>CTT]. 38 8 71
19065339 2008
3
A new case of Hb F-M-Osaka [G gamma 63(E7)His-->Tyr] showed only benign neonatal cyanosis. 38 8 71
8811323 1996
4
Hemoglobin F-Cincinnati, alpha 2G gamma 2 41(C7) Phe-->Ser in a newborn with cyanosis. 38 8 71
7741137 1995
5
Mutant fetal hemoglobin causing cyanosis in a newborn. 38 8 71
2470017 1989
6
Hb F-M-Osaka [Ggamma63(E7)His --> tyr] in a newborn from southwest France. 8 71
12603090 2003
7
Hemoglobin FM-Fort Ripley: another lesson from the neonate. 8 71
2470018 1989
8
Hb F-M-Osaka or alpha 2G gamma 2(63)(E7)His----Tyr in a Caucasian male infant. 8 71
2483933 1989
9
A new abnormal fetal hemoglobin, Hb FM-Osaka (alpha 2 gamma 2 63His replaced by Tyr). 8 71
6158500 1980
10
Asymptomatic congenital tracheal stenosis. 38
31388427 2019
11
Noninvasive Monitoring and Assessment of Oxygenation in Infants. 38
31345538 2019
12
Validation of the British Thoracic Society Severity Criteria for Pediatric Community-acquired Pneumonia. 38
31232897 2019
13
Pulmonary Artery Obstruction by Idiopathic Calcification Causing Sudden Collapse in a Neonate. 38
30684481 2019
14
[Vascular rings. Series of 28 patients of a Pediatrie Respiratory Endoscopy Department]. 38
31339282 2019
15
Hereditary methemoglobinemia caused by Hb M-Hyde Park (Hb M-Akita) (HBB:c.277C > T; p.His93Tyr). 38
31267164 2019
16
To compare nasal mask with binasal prongs in delivering continuous positive airway pressure for reducing need of invasive ventilation: randomized controlled trial. 38
31394955 2019
17
Saline Contrast Transesophageal Echocardiography in Fontan Patients: Assessment of the Presence, Type, and Size of Right to Left Shunts. 38
31218373 2019
18
[Clinical analysis of methylmalonic acidemia and hyperhomocysteinemia with diffuse lung disease as an initial or main presentation]. 38
31352748 2019
19
Cyanosis With Dysautonomia Mimics Raynaud Disease. 38
31389817 2019
20
Generalized tonic seizures with autonomic signs are the hallmark of SCN8A developmental and epileptic encephalopathy. 38
31174070 2019
21
Complex Congenital Heart Malformation Including Transposition of the Great Vessels, Presenting as Sudden Unexplained Infant Death. 38
30485421 2019
22
Atrial fibrillation in adults with congenital heart disease. 38
30712848 2019
23
A new palliative surgical technique for high risk Total anomalous pulmonary venous connection (Sarmast-Takriti shunt). 38
31262322 2019
24
Echocardiographic evaluation of univentricular physiology and cavopulmonary shunts. 38
31246324 2019
25
Emergent Decompression of Intracranial Abscess in Eisenmenger Syndrome. 38
31295595 2019
26
Adverse Perioperative Events in Children with Complex Congenital Heart Disease Undergoing Operative Scoliosis Repair in the Contemporary Era. 38
31350568 2019
27
Prehospital clinical presentation in patients with acute coronary syndrome complicated by cardiogenic shock: A single center study. 38
30213588 2019
28
Early palliative balloon pulmonary valvuloplasty in neonates and young infants with tetralogy of Fallot. 38
31302722 2019
29
Misdiagnosis and pitfalls in Panayiotopoulos syndrome. 38
31369969 2019
30
Clinical presentation and outcome in congenital pulmonary malformation: 25 year retrospective study in Thailand. 38
31264305 2019
31
Perforation of the atretic pulmonary valve using chronic total occlusion (CTO) wire and coronary microcatheter. 38
31290594 2019
32
Pattern of un-operated Grown Up Congenital Heart (GUCH) patients presenting to a Tertiary Care Cardiac Institute of Punjab. 38
31372144 2019
33
Operable ventricular septal defect despite severe pulmonary hypertension and cyanosis! 38
31331408 2019
34
A rare cause of cyanosis since birth: Hb M-Iwate 38
31327183 2019
35
Association Between Cyanosis, Transfusion, and Thrombotic Complications in Neonates and Children Undergoing Cardiac Surgery. 38
31399304 2019
36
A Case of Dextrotransposition of the Great Arteries Type I with Reversed Differential Cyanosis. 38
31360611 2019
37
Image Diagnosis - Interrupted Aortic Arch in a Child With Differential Cyanosis. 38
30787249 2019
38
Exon sequencing of the alpha-2-globin gene for the differential diagnosis of central cyanosis in newborns: a case report. 38
31269924 2019
39
Fistula between the right pulmonary artery and the left atrium coexisting with a secundum-type atrial septal defect: An unusual case of cyanosis in a girl. 38
31215690 2019
40
Pulmonary arteriovenous malformations in a patient with single ventricle and polysplenia syndrome. 38
31270088 2019
41
The Complexity of Diagnosing High-Altitude Pulmonary Edema: A Case Report and Review of the Differential Diagnosis of Greater Than Expected Hypoxemia at Altitude. 38
31233382 2019
42
Biatrial drainage of right superior caval vein with preferential streaming into the left atrium. 38
31204631 2019
43
Aortopulmonary window in adults: A rare entity leading to Eisenmenger syndrome. 38
31116466 2019
44
[Asymmetric crying facies and vocal cord paralysis accompanied by congenital heart disease in an infant]. 38
31208514 2019
45
Drug-Eluting Stents Compared With Bare Metal Stents for Stenting the Ductus Arteriosus in Infants With Ductal-Dependent Pulmonary Blood Flow. 38
31350000 2019
46
Neurodevelopmental Delay following the Neonatal Repair of Coarctation and Arch Obstruction. 38
31207245 2019
47
Comparative molecular characterization, pathogenicity and seroprevalence of avian influenza virus H9N2 in commercial and backyard poultry flocks. 38
31174705 2019
48
Diagnosis and treatment of congenital tuberculosis: a systematic review of 92 cases. 38
31182120 2019
49
Accuracy of pulse oximeters at low oxygen saturations in children with congenital cyanotic heart disease: An observational study. 38
30938906 2019
50
Assessing the Incidence of Symptomatic Respiratory Syncytial Virus (RSV) Illness within a Prospective Birth Cohort in Managua, Nicaragua. 38
31257406 2019
51
Neonatal Pertussis, an Under-Recognized Health Burden and Rationale for Maternal Immunization: A Systematic Review of South and South-East Asian Countries. 38
31054089 2019
52
Associations Between Age at Arterial Switch Operation, Brain Growth, and Development in Infants With Transposition of the Great Arteries. 38
31132861 2019
53
Clinical characteristics and outcomes of hypersensitivity pneumonitis: a population-based study in China. 38
31021982 2019
54
Clinical and molecular characterization of Korean children with infantile and late-onset Pompe disease: 10 years of experience with enzyme replacement therapy at a single center. 38
30360039 2019
55
Short stature among children undergoing cardiac surgery for congenital heart defects. 38
31063303 2019
56
Common Arterial Trunk: Physiology, Imaging, and Management. 38
30596352 2019
57
Did This Patient Have Cardiac Syncope?: The Rational Clinical Examination Systematic Review. 38
31237649 2019
58
Primary Pulmonary Hypertension Associated with Asymptomatic Methylmalonic Aciduria in a Child. 38
31142418 2019
59
Eisenmenger syndrome and other types of pulmonary arterial hypertension related to adult congenital heart disease. 38
31120797 2019
60
Novel shunt modification with an adjustable stent-embedded "fenestrated" septal occluder in a patient with pulmonary hypertension. 38
30838741 2019
61
Clinical Cyanosis in a Patient Presenting for Outpatient Colonoscopy: A Case Report of Hemoglobin Kansas. 38
30640277 2019
62
Early Experience With Sacubitril/Valsartan in Adult Patients With Congenital Heart Disease. 38
31084317 2019
63
Weil's disease with haemoptysis and acute respiratory distress syndrome. 38
31151976 2019
64
Code Blue: Life-threatening Methemoglobinemia. 38
31061960 2019
65
Determinants of long-term outcome of repaired pulmonary valve stenosis. 38
31130344 2019
66
Positional asphyxia in a work-related fatality. 38
31119506 2019
67
Clinical and epidemiological characteristics of whooping cough in hospitalized patients of a tertiary care hospital in Peru. 38
31141085 2019
68
Idiopathic acute massive pulmonary embolism in childhood. 38
31089032 2019
69
Predicted clinical factors associated with the intensive care unit length of stay after total cavopulmonary connection. 38
30578061 2019
70
Acute Opiate Overdose: An Update on Management Strategies in Emergency Department and Critical Care Unit. 38
28952972 2019
71
Atrioventricular septal defect and tetralogy of Fallot - A single tertiary center experience: A retrospective review. 38
31143034 2019
72
Ulnar Artery Thrombosis Presented with Unilateral Raynaud's Phenomenon Findings after Long-Term Intensive Handicraft Activity: Hypothenar Hammer Syndrome. 38
30711504 2019
73
Value of Rotational Thromboelastometry and Impedance Aggregometry for Evaluating Coagulation Disorders in Patients With Cyanotic and Nongenetic Congenital Heart Disease. 38
30885417 2019
74
Hepatic Vein Incorporation Into the Azygos System in Heterotaxy and Interrupted Inferior Vena Cava. 38
31084312 2019
75
Physiologic diagnosis of congenital heart disease in cyanotic neonates. 38
30730315 2019
76
Therapeutic Role of Zinc Supplementation in Children Hospitalized with Pneumonia. 38
31249752 2019
77
[Surgical Repair of Ebstein's Anomaly in the Adult]. 38
31266914 2019
78
Congenital bronchobiliary fistula: A case report and review of the literature. 38
31024960 2019
79
Recessive congenital methemoglobinemia type II: Hypoplastic basal ganglia in two siblings with a novel mutation of the cytochrome b5 reductase gene. 38
30614390 2019
80
How does ballet training alter ankle tendinous morphology and hemodynamics in asymptomatic pre-professional dancers? An ultrasonographic study. 38
30297215 2019
81
Acute therapy of newborns with critical congenital heart disease. 38
31161078 2019
82
Fatal inhalation of volcanic gases in three tourists of a geothermal area. 38
30777401 2019
83
Left upper lobectomy for a large incidental simple arteriovenous malformation. 38
31191141 2019
84
Rare neonatal interstitial lung disease masquerading as pulmonary hemosiderosis. 38
31023731 2019
85
Catheterization Performed in the Early Postoperative Period After Congenital Heart Surgery in Children. 38
30830282 2019
86
Successful Management of Pulmonary Arterial Hypertension by Monitoring N-Terminal Pro-B-Type Natriuretic Peptide Serum Levels in a Preterm Infant with Chronic Lung Disease: A Case Report. 38
30972228 2019
87
Type I right pulmonary artery to left atrium fistula: a rare differential of cyanosis in adults. 38
30942123 2019
88
Rare case of a superior sinus venosus atrial septal defect presenting with cyanosis. 38
30950362 2019
89
A neonate with pneumoperitoneum and cyanosis of lower limbs skin during esophagogastroduodenoscopy. 38
30635195 2019
90
Assessment and Validation of Syndromic Case Definitions for Respiratory Syncytial Virus Testing in a Low Resource Population. 38
30074977 2019
91
Infantile cardiac hemangioma causing right ventricular inflow obstruction. 38
30862170 2019
92
Removal of a minimal amount of subdural hematoma is effective and sufficient for term neonates with severe symptomatic spontaneous parenchymal hemorrhage. 38
30879127 2019
93
Congenital methaemoglobinaemia diagnosed in an adolescent boy. 38
30936348 2019
94
Body Coloration Artifacts Encountered at Medicolegal Autopsy in India. 38
30864959 2019
95
Congenital Methemoglobinemia Identified by Pulse Oximetry Screening. 38
30733239 2019
96
Should transcatheter closure of atrial septal defects with inferior-posterior deficient rim still be attempted? 38
31019758 2019
97
Genetic cause for congenital methemoglobinemia in an Australian Pomeranian dog. 38
30767280 2019
98
The prevention of severe pertussis and pertussis deaths in young infants. 38
30736722 2019
99
Outcome of pregnancies in women with pulmonary hypertension: a single-centre experience from South India. 38
30868706 2019
100
Hybrid procedure of right ventricle outflow tract stenting in small infants with pulmonary atresia and ventricular septal defect: early and mid-term results from a single centre. 38
30724146 2019
101
Clinical Aspects and Evolution under Current Treatments on Pulmonary Alveolar Phospholipoproteinosis Patients. 38
31237860 2019
102
Methemoglobinemia: Infants at risk. 38
30956100 2019
103
Aetiology and risks factors associated with the fatal outcomes of childhood pneumonia among hospitalised children in the Philippines from 2008 to 2016: a case series study. 38
30928958 2019
104
[A rare cause of exertional dyspnea and cyanosis in an adolescent patient: Pulmonary arteriovenous malformation and successful treatment]. 38
30874507 2019
105
A pulmonary arteriovenous malformation treated with percutaneous intervention. 38
30874504 2019
106
[Autointoxication with 'suicide powder']. 38
30875162 2019
107
Tracheoscopic Findings and Their Impact on Respiratory Symptoms in Children with Esophageal Atresia. 38
30900225 2019
108
[Anesthetic management for patient with severe cyanosis following bioprosthetic valve stenosis]. 38
30446210 2019
109
A Novel Brain Injury Biomarker Correlates with Cyanosis in Infants with Congenital Heart Disease. 38
30430186 2019
110
Maternal and fetal outcomes in pregnancy complicated with Eisenmenger syndrome. 38
30910135 2019
111
Congenital bilateral dacryocystocele. 38
30337239 2019
112
Pneumocystis jirovecii pneumonia as an initial manifestation of hyper-IgM syndrome in an infant: A case report. 38
30762803 2019
113
Methemoglobinemia Associated with Late-Onset Neonatal Sepsis: A Single-Center Experience. 38
30708394 2019
114
Heart beat but not respiration is the main driving force of the systemic venous return in the Fontan circulation. 38
30765829 2019
115
Total anomalous pulmonary venous connection in a mature dog. 38
30797440 2019
116
Aortopulmonary window in tetralogy of Fallot with absent conal septum. 38
30585348 2019
117
A 10-year-old boy with dyspnea and hypoxia: abernathy malformation masquerading as pulmonary arteriovenous fistula. 38
30744582 2019
118
Rare presentation of granulomatosis with polyangiitis. 38
30798274 2019
119
Hypoxia due to intrapulmonary vascular dilatation in a toddler with a congenital portacaval shunt: case report. 38
30795758 2019
120
The mysterious "double" arch. 38
30628131 2019
121
Benzocaine-Induced Methemoglobinemia in a Postoperative Bariatric Patient following Esophagogastroduodenoscopy. 38
30918726 2019
122
Seventy-six-year-old man with progressive dyspnoea. 38
30282641 2019
123
[Hb Hirosaki hemoglobinopathy initially suspected due to low oxygen saturation levels and abnormally low HbA1c levels]. 38
31068518 2019
124
[Breve reseña histórica de la primera publicación del síndrome de insuficiencia respiratoria aguda]. 38
30600805 2019
125
Methaemoglobinemia Induced by Poppers and Bupropion Intoxication in the Emergency Department. 38
30931283 2019
126
Concomitant cryoglobulinemic vasculitis and cold agglutinin disease successfully treated with bortezomib: A case report. 38
30681592 2019
127
Clinical characteristics and effective treatments of scrub typhus-associated hemophagocytic lymphohistiocytosis in children. 38
30581619 2019
128
High incidence of ductal closure or narrowing at birth in patients with right ventricular outflow tract obstruction with normal orientation of the ductus arteriosus. 38
30352636 2019
129
Suspected Adverse Drug Reactions Related to Breast Cancer Chemotherapy: Disproportionality Analysis of the Brazilian Spontaneous Reporting System. 38
31139083 2019
130
Late diagnosis of total anomalous pulmonary venous drainage in a 5.5-month-old infant. 38
31088016 2019
131
Compound Heterozygous CHAT Gene Mutations of a Large Deletion and a Missense Variant in a Chinese Patient With Severe Congenital Myasthenic Syndrome With Episodic Apnea. 38
30914958 2019
132
Risk factors for hospitalization of patients with chikungunya virus infection at sentinel hospitals in Puerto Rico. 38
30640900 2019
133
Study on the Differences between Traditional Chinese Medicine Syndromes in NYHA I-IV Classification of Chronic Heart Failure. 38
30854005 2019
134
Outcomes of Single Ventricle Patients Undergoing the Kawashima Procedure: Can We Do Better? 38
30799723 2019
135
Evaluation of foreign body aspiration cases in our pediatric intensive care unit: Single-center experience. 38
31217709 2019
136
Association of plasma soluble CD14 level with asthma severity in adults: a case control study in China. 38
30691461 2019
137
Tetralogy of Fallot with isolated levocardia in a young female. 38
31258874 2019
138
The ugly face of deep vein thrombosis: Phlegmasia Cerulea Dolens-Case report. 38
31128546 2019
139
The mystery of 'saturation gap': a case of dapsone-induced methaemoglobinemia in a pregnant mother with leprosy. 38
30697428 2019
140
Pulmonary arteriovenous malformation revealed by a chronic cyanosis. 38
30650027 2019
141
Management of the Adult Patient With Congenitally Corrected Transposition: Challenges and Uncertainties. 38
31027566 2019
142
Anomalous Connection of the Right Superior Vena Cava to the Left Atrium in a Child with Bilateral Superior Vena Cavae: An Unusual Cause of Cyanosis. 38
30353313 2019
143
A case of DAPSONE INDUCED METHEMOGLOBINEMIA. 38
31249693 2019
144
Breath-Holding Spells in Pediatrics: A Narrative Review of the Current Evidence. 38
30421679 2019
145
Complex pulmonary arteriovenous fistula in mother and daughter: Case report. 38
30633165 2019
146
Apnea, Cyanosis, and Septic Shock in a Term Neonate. 38
31218243 2019
147
Chronic Hepatitis C with Cyanosis. 38
30733879 2019
148
Microcirculatory Differences in Children With Congenital Heart Disease According to Cyanosis and Age. 38
31312623 2019
149
Terlipressin-Induced Peripheral Cyanosis in a Patient with Liver Cirrhosis and Hepatorenal Syndrome. 38
30600312 2019
150
Novel use of covered stents to treat profound cyanosis in a hepatic vein exclusion Fontan. 38
30745773 2019
151
Blue Is the Warmest Color: The Effect of Cyanosis and Heart Disease on Risk of Adverse Events During Tracheal Intubation. 38
30614973 2019
152
Cor triatriatum dexter with right ventricular hypoplasia: Role of multimodality imaging in decision making. 38
30414206 2018
153
Congenital high airway obstruction with tracheoesophageal fistula: A case report. 38
30572501 2018
154
The clinical characteristics and prognosis of subgaleal hemorrhage in newborn. 38
30304906 2018
155
Single-centre experience in stenting arterial shunts for adult CHD patients with single-ventricle physiology and pulmonary blood flow dependent on arterial shunts. 38
30309400 2018
156
Outcomes and swallowing evaluations after injection laryngoplasty for type I laryngeal cleft: Does age matter? 38
30368367 2018
157
Uhl's disease: An uncommon presentation of a rare disease. 38
30001957 2018
158
Anomalous Origin of the Right Subclavian Artery in a Patient with D-transposition of the Great Arteries. 38
30588450 2018
159